HUT66162A - In 16-position quaternizated, substituted with amino-group androstane-derivatives and process for their production - Google Patents

In 16-position quaternizated, substituted with amino-group androstane-derivatives and process for their production

Info

Publication number
HUT66162A
HUT66162A HU9203436A HU9203436A HUT66162A HU T66162 A HUT66162 A HU T66162A HU 9203436 A HU9203436 A HU 9203436A HU 9203436 A HU9203436 A HU 9203436A HU T66162 A HUT66162 A HU T66162A
Authority
HU
Hungary
Prior art keywords
substituted
production
derivatives
quaternizated
amino
Prior art date
Application number
HU9203436A
Other languages
English (en)
Other versions
HU210076B (en
HU9203436D0 (en
Inventor
E Szilveszter Vizi
Zoltan Tuba
Sandor Maho
F Ferenc Foeldes
Original Assignee
Vizi E
Tuba
Maho
F Ferenc Foeldes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vizi E, Tuba, Maho, F Ferenc Foeldes filed Critical Vizi E
Priority to HU9203436A priority Critical patent/HU210076B/hu
Publication of HU9203436D0 publication Critical patent/HU9203436D0/hu
Priority to AU49005/93A priority patent/AU665866B2/en
Priority to NZ248956A priority patent/NZ248956A/en
Priority to CA002108741A priority patent/CA2108741A1/en
Priority to IL10733193A priority patent/IL107331A/en
Priority to UA93002174A priority patent/UA27230C2/uk
Priority to JP5266920A priority patent/JP2834651B2/ja
Priority to US08/141,535 priority patent/US5591735A/en
Priority to ES93117558T priority patent/ES2103413T3/es
Priority to AT93117558T priority patent/ATE154030T1/de
Priority to DE69311295T priority patent/DE69311295T2/de
Priority to RU93049598A priority patent/RU2124021C1/ru
Priority to EP93117558A priority patent/EP0608495B1/en
Priority to DK93117558.2T priority patent/DK0608495T3/da
Priority to KR1019930023012A priority patent/KR0179399B1/ko
Priority to CN93119822A priority patent/CN1041937C/zh
Priority to BR9304466A priority patent/BR9304466A/pt
Priority to EE9400067A priority patent/EE03073B1/xx
Publication of HUT66162A publication Critical patent/HUT66162A/hu
Publication of HU210076B publication Critical patent/HU210076B/hu
Priority to GR970401666T priority patent/GR3024011T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9203436A 1992-11-02 1992-11-02 Process for producing androstane derivatives substituted with quaternisaeted amino group in 16-position and for producing pharmaceutical compositions containing them HU210076B (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
HU9203436A HU210076B (en) 1992-11-02 1992-11-02 Process for producing androstane derivatives substituted with quaternisaeted amino group in 16-position and for producing pharmaceutical compositions containing them
AU49005/93A AU665866B2 (en) 1992-11-02 1993-10-14 Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same
NZ248956A NZ248956A (en) 1992-11-02 1993-10-14 Androstane derivatives; preparation and pharmaceutical compositions
CA002108741A CA2108741A1 (en) 1992-11-02 1993-10-19 Androstane derivatives substituted by a quaternary ammonium group in 16- position, pharmaceutical compositions containing them and process for preparing same
IL10733193A IL107331A (en) 1992-11-02 1993-10-20 History of androstane converted to 61st place in a quarterly ammonium group, pharmaceutical mixtures containing them and process for their preparation
UA93002174A UA27230C2 (uk) 1992-11-02 1993-10-25 Похідні андростану, заміщені по 16-му положенню четвертинною амонієвою групою, для використання як нервово-м'язових блокаторів та фармацевтична композиція, що здатна викликати нервово-м'язову блокаду
JP5266920A JP2834651B2 (ja) 1992-11-02 1993-10-26 16位が四級アンモニウム基で置換されたアンドロスタン誘導体、それを含有する医薬組成物およびそれらの製造法
US08/141,535 US5591735A (en) 1992-11-02 1993-10-27 Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same
DK93117558.2T DK0608495T3 (da) 1992-11-02 1993-10-29 Androstanderivater substitueret med en kvaternær ammoniumgruppe i 16-stillingen, farmaceutiske præparater indeholdende disse derivater og fremgangsmåde til deres fremstilling.
ES93117558T ES2103413T3 (es) 1992-11-02 1993-10-29 Derivados del androstano sustituidos por un grupo amonio cuaternario en la posicion 16, composiciones farmaceuticas que los contienen y procedimientos para prepararlos.
AT93117558T ATE154030T1 (de) 1992-11-02 1993-10-29 16-(quaternär-ammoniak)-substituierte androstan- derivate, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE69311295T DE69311295T2 (de) 1992-11-02 1993-10-29 16-(quaternär-Ammoniak)-substituierte Androstan-Derivate, pharmazeutische Präparate davon und ein Verfahren zu ihrer Herstellung
RU93049598A RU2124021C1 (ru) 1992-11-02 1993-10-29 Производные андростана, замещенные по 16-положению четвертичной аммониевой группой, фармацевтическая композиция
EP93117558A EP0608495B1 (en) 1992-11-02 1993-10-29 Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same
KR1019930023012A KR0179399B1 (ko) 1992-11-02 1993-11-01 16-위치에 사차 암모늄기가 치환된 안드로스테인 유도체, 그를 함유하는 제약학적 조성물 및 그의 제조방법
CN93119822A CN1041937C (zh) 1992-11-02 1993-11-02 雄甾烷衍生物及其药物组合物和制备方法
BR9304466A BR9304466A (pt) 1992-11-02 1993-11-03 Derivados do androstano, composiçao farmacêutica contendo esses derivados, processo para preparaçao dos mesmos, compostos intermediários, processo para preparaçao da dita composiçao e processo para bloquear a transmissao de impulsos nervosos (estímulos) a músculos estriados
EE9400067A EE03073B1 (et) 1992-11-02 1994-06-29 Androstaani derivaadid, mis on 16. asendis asendatud kvaternaarse ammooniumrühmaga, neid sisaldavad farmatseutilised segud ja nende valmistamise protsess
GR970401666T GR3024011T3 (en) 1992-11-02 1997-07-08 Androstane derivatives substituted by a quaternary ammonium group in 16-position, pharmaceutical compositions containing them and process for preparing same.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9203436A HU210076B (en) 1992-11-02 1992-11-02 Process for producing androstane derivatives substituted with quaternisaeted amino group in 16-position and for producing pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
HU9203436D0 HU9203436D0 (en) 1993-01-28
HUT66162A true HUT66162A (en) 1994-09-28
HU210076B HU210076B (en) 1995-01-30

Family

ID=10982503

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9203436A HU210076B (en) 1992-11-02 1992-11-02 Process for producing androstane derivatives substituted with quaternisaeted amino group in 16-position and for producing pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US5591735A (hu)
EP (1) EP0608495B1 (hu)
JP (1) JP2834651B2 (hu)
KR (1) KR0179399B1 (hu)
CN (1) CN1041937C (hu)
AT (1) ATE154030T1 (hu)
AU (1) AU665866B2 (hu)
BR (1) BR9304466A (hu)
CA (1) CA2108741A1 (hu)
DE (1) DE69311295T2 (hu)
DK (1) DK0608495T3 (hu)
EE (1) EE03073B1 (hu)
ES (1) ES2103413T3 (hu)
GR (1) GR3024011T3 (hu)
HU (1) HU210076B (hu)
IL (1) IL107331A (hu)
NZ (1) NZ248956A (hu)
RU (1) RU2124021C1 (hu)
UA (1) UA27230C2 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020123928A1 (en) * 2001-01-11 2002-09-05 Eldering Charles A. Targeting ads to subscribers based on privacy-protected subscriber profiles
US7200804B1 (en) * 1998-12-08 2007-04-03 Yodlee.Com, Inc. Method and apparatus for providing automation to an internet navigation application
WO2001065453A1 (en) * 2000-02-29 2001-09-07 Expanse Networks, Inc. Privacy-protected targeting system
WO2007073424A1 (en) * 2005-09-13 2007-06-28 Sicor, Inc. Pure rocuronium bromide
CN102675402A (zh) * 2012-05-16 2012-09-19 武汉大学 4,16β-二胺基甾体季铵盐衍生物及其制备方法和应用
CN109053855B (zh) * 2018-10-08 2020-02-14 台州仙琚药业有限公司 一种16β-四氢吡咯基雄甾-2α-环氧-17-酮的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165600B (hu) * 1972-07-27 1974-09-28
US4177190A (en) * 1975-08-01 1979-12-04 Richter Gedeon Vegyeszeti Gyar Rt. Diamino-androstanes and a process for the preparation of the said compounds
DE2962627D1 (en) * 1978-09-05 1982-06-09 Akzo Nv Acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same
GB8708886D0 (en) * 1987-04-14 1987-05-20 Akzo Nv 2beta-morpholino-androstane derivatives
GB8804579D0 (en) * 1988-02-26 1988-03-30 Akzo Nv Novel 16-homo-piperidino-androstane derivatives & processes for their preparation

Also Published As

Publication number Publication date
JPH06192288A (ja) 1994-07-12
ATE154030T1 (de) 1997-06-15
DE69311295D1 (de) 1997-07-10
EP0608495A3 (en) 1995-12-20
KR0179399B1 (ko) 1999-04-01
HU210076B (en) 1995-01-30
HU9203436D0 (en) 1993-01-28
EP0608495A2 (en) 1994-08-03
US5591735A (en) 1997-01-07
IL107331A (en) 1998-12-06
UA27230C2 (uk) 2000-08-15
ES2103413T3 (es) 1997-09-16
DE69311295T2 (de) 1997-10-30
EP0608495B1 (en) 1997-06-04
CN1090852A (zh) 1994-08-17
JP2834651B2 (ja) 1998-12-09
NZ248956A (en) 1995-08-28
CA2108741A1 (en) 1994-05-03
AU665866B2 (en) 1996-01-18
CN1041937C (zh) 1999-02-03
KR940011476A (ko) 1994-06-21
BR9304466A (pt) 1994-06-14
IL107331A0 (en) 1994-01-25
DK0608495T3 (da) 1997-08-04
AU4900593A (en) 1995-06-08
RU2124021C1 (ru) 1998-12-27
GR3024011T3 (en) 1997-10-31
EE03073B1 (et) 1998-02-16

Similar Documents

Publication Publication Date Title
HUT68029A (en) New 11-benzaldoxim-estradiene derivatives, pharmaceutical compositions containing them and process for producing them
AU6334094A (en) Process for producing phosphorescent yarn and yarn produced by the process
HU175963B (en) Process for producing biologically active polimers of 3-square bracket-n-comma above-bracket-3-halogeno-propyl-bracket closed-n-comma above-methyl-amino-square bracket closed-n,n,n-trimethyl-1-propanaminium-halogenides
HUT59558A (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum
PL289487A1 (en) Method of producing new aminophenol derivatives
HU9402695D0 (en) New 11-benzaldoxime-17-beta-methoxi-17-alpha-methoxy-methyl-estradiene derivatives, pharmaceutical compositions containing them and process for producing them
UA6044A1 (uk) Спосіб одержання метіленових похідних андроста-1,4 -діен-3,17-діона
HUT50345A (en) Process for production of cefem-derivatives and their intermediers
HUT66162A (en) In 16-position quaternizated, substituted with amino-group androstane-derivatives and process for their production
TW230775B (hu)
HUT54345A (en) Process for producing new, antiarrhythmic, sulfur-containing cyanophenol derivatives and medical compositions comprising same
ES2058029A1 (es) Proceso para la produccion de sales del acido clavulanico.
HUT61570A (en) Process for producing pregna-1,4-diene-3,20-dione derivatives
EP0434571A3 (en) New steroid derivatives with a substituted ethyl group on the position 10, process for their production, their use as medicines and pharmaceutical compositions containing them
HUT58700A (en) Process for producing dialkyl-pyridine-2,3-dicarboxylate and derivatives from dialkyl-dichloro-mateate
ES456243A1 (es) Un procedimiento de preparacion de compuestos de aminoalcoxi4-(2h)-piranona-2, sustituidos en posicion 3 y condensados en posicion 5,6.
DE3586472D1 (de) Nichtstaubende antibiotische vormischungszusammensetzungen gegen coccidiose und verfahren zu deren herstellung.
NO177099C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive steroidderivater
HUT62472A (en) Process for producing locqlly applicable pharmaceutically compositions
NO308583B1 (no) Anvendelse av steroider for fremstilling av et medikament for behandling av forstyrrelser indusert av østrogenmangel, steroidene samt farmasøytisk blanding
UA37179C2 (uk) Кристалічні моногідрати гідрохлориду ендо-2,3-дигідро-n-(8-метил-8-азабіцикло [ 3.2.1 ] окт-3-іл) -2-оксо-1н-бензимідазол-1-карбоксаміду та ендо-3-етил-2,3-дигідро-n-(8-метил-8-азабіцикло[3.2.1]окт-3-іл)-2-оксо-1н-бензимідазол-1-карбоксаміду, спосіб їх одержання та фармацевтична композиція
HU174882B (hu) Sposob poluchenija proizvodnykh 1,12-metanooksimetano-indolo-kvadratnaja skobka-2,3-a-kvadratnaja skobka zakryta-kinolizina i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
IE43872L (en) 2,9-dioxatricyclo [4.3.1.0(3,7)] decanes
HUT50476A (en) Process for producing 3-pyrrolidinyl-thio-1-azabicyclo/3,2,0/hept-2-ene-2-carboxylic acid derivatives
NO177676C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive steroider med 2,19-methylenoxy- eller 2,19-methylenthio-bro

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: RICHTER GEDEON VEGYESZETI GYAR RT., HU

HC9A Change of name, address

Owner name: RICHTER GEDEON NYRT., HU

Free format text: FORMER OWNER(S): RICHTER GEDEON VEGYESZETI GYAR RT., HU; DR. TUBA ZOLTAN, HU; DR. FOELDES F. FERENC, US; DR. VIZI E. SZILVESZTER, HU; MAHO SANDOR, HU

MM4A Lapse of definitive patent protection due to non-payment of fees